Janus Henderson Investors US’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q1
$82.5M Buy
5,501,755
+925,948
+20% +$13.9M 0.07% 330
2016
Q4
$59.9M Buy
4,575,807
+542,007
+13% +$7.1M 0.05% 401
2016
Q3
$69.5M Buy
4,033,800
+19,879
+0.5% +$343K 0.06% 361
2016
Q2
$72.5M Buy
4,013,921
+516,166
+15% +$9.32M 0.06% 356
2016
Q1
$66.4M Buy
3,497,755
+366,408
+12% +$6.96M 0.06% 364
2015
Q4
$83.6M Buy
3,131,347
+549,329
+21% +$14.7M 0.07% 316
2015
Q3
$63M Buy
2,582,018
+1,225,944
+90% +$29.9M 0.06% 369
2015
Q2
$42.3M Buy
+1,356,074
New +$42.3M 0.03% 471